HBIO vs PLSE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

HBIO

55.2
AI Score
VS
HBIO Wins

PLSE

50.4
AI Score

Investment Advisor Scores

HBIO

55score
Recommendation
HOLD

PLSE

50score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric HBIO PLSE Winner
Revenue 43.48M 835,000 HBIO
Net Income -6.33M -43.24M HBIO
Net Margin -14.6% -5178.2% HBIO
Operating Income -2.15M -44.42M HBIO
ROE -85.4% -43.5% PLSE
ROA -8.3% -37.4% HBIO
Total Assets 76.29M 115.56M PLSE
Cash 6.50M 101.62M PLSE
Current Ratio 1.87 9.63 PLSE
Free Cash Flow -1.45M -33.43M HBIO

Relative Price Performance (Last 90 Days)

HBIO 1M: +4.2% · 3M: +39.8% PLSE 1M: +2.3% · 3M: +76.0%

Current Technical Phase

HBIO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (11.6% over 20 days), RSI 58

RSI (14): 58.1 · Price: $8.39

PLSE

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (13.1% over 20 days), RSI 58

RSI (14): 57.9 · Price: $53.20

Fundamentals Snapshot

Metric HBIO PLSE
Market Cap — —
Forward P/E 13.2 -43.9
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.6% 0.0%
Operating Margin 0.0% -58.2%
EPS -2.31 -1.18
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, HBIO is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.